CompletedNCT00025792
Pramipexole added to mood stabilizers for bipolar depression
About this title
Clinical Trial of Pramipexole in Bipolar Depression
Read the official source — NCT00025792Medication studyUnited StatesBipolarity
Understand this study
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateOctober 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 200
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT00025792
- Official title
Show the full official title
An Investigation of the Antidepressant Efficacy of a Dopamine Agonist With Neurotrophic Properties in Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including Pramipexole.
